中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

不同饮食及运动方案对非酒精性脂肪性肝病患者的影响

汪涛 蒋元烨 王学伟 曹勤 季光

引用本文:
Citation:

不同饮食及运动方案对非酒精性脂肪性肝病患者的影响

DOI: 10.3969/j.issn.1001-5256.2020.02.045
基金项目: 

国家自然科学基金青年项目(81703879); 上海市卫计委临床研究专项面上项目(201840377); 上海市普陀区中心医院人才培养项目(2016212B);上海市普陀区中心医院重点专科资助项目(2016103A); 

详细信息
  • 中图分类号: R575.5

Effect of different diet and exercise strategies on patients with nonalcoholic fatty liver disease

Research funding: 

 

  • 摘要:

    非酒精性脂肪性肝病(NAFLD)发病率逐年攀升,目前已是全球最常见的肝脏疾病之一。合理的饮食及运动是目前公认的治疗NAFLD最为关键的一步,也是管理NAFLD患者的基石,但是,由于各种客观原因,不同国家、地区、学会对NAFLD患者制定的饮食及运动方案不尽相同。对近年来不同国家、地区及不同文献所报道的干预NAFLD患者的饮食及运动方案作一综述,以期为临床医生指导NAFLD患者制订合理的饮食及运动策略提供依据。

     

  • [1] RINELLA ME. Nonalcoholic fatty liver disease:A systematic review[J]. JAMA,2015,313(22):2263-2273.
    [2] DIEHL AM,DAY C. Cause,pathogenesis,and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med,2017,377(21):2063-2072.
    [3] LOOMBA R,SANYAL AJ. The global NAFLD epidemic[J].Nat Rev Gastroenterol Hepatol,2013,10(11):686-690.
    [4] WONG RJ,AGUILAR M,CHEUNG R,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J]. Gastroenterology,2015,148(3):547-555.
    [5] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64(1):73-84.
    [6] FARRELL GC,WONG VW,CHITTURI S. NAFLD in Asia—as common and important as in the West[J]. Nat Rev Gastroenterol Hepatol,2013,10(5):307-318.
    [7] LI Z,XUE J,CHEN P,et al. Prevalence of nonalcoholic fatty liver disease in mainland of China:A meta-analysis of published studies[J]. J Gastroenterol Hepatol,2014,29(1):42-51.
    [8] ESTES C,ANSTEE QM,ARIAS-LOSTE MT,et al. Modeling NAFLD disease burden in China,France,Germany,Italy,Japan,Spain,United Kingdom,and United States for the period2016-2030[J]. J Hepatol,2018,69(4):896-904.
    [9] ROSQVIST F,IGGMAN D,KULLBERG J,et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans[J]. Diabetes,2014,63(7):2356-2368.
    [10] RYAN MC,ITSIOPOULOS C,THODIS T,et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease[J]. J Hepatol,2013,59(1):138-143.
    [11] HEKMATDOOST A,SHAMSIPOUR A,MEIBODI M,et al. Adherence to the Dietary Approaches to Stop Hypertension(DASH)and risk of nonalcoholic fatty liver disease[J]. Int J Food Sci Nutr,2016,67(8):1024-1029.
    [12] SHIRANI F,SALEHI-ABARGOUEI A,AZADBAKHT L. Effects of Dietary Approaches to Stop Hypertension(DASH)diet on some risk for developing type 2 diabetes:A systematic review and meta-analysis on controlled clinical trials[J]. Nutrition,2013,29(7-8):939-947.
    [13] MARDINOGLU A,WU H,BJORNSON E,et al. An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans[J]. Cell Metab,2018,27(3):559-571.
    [14] SCHWIMMER JB,UGALED-NICALO P,WELSH JA,et al.Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys:A randomized clinical trial[J]. JAMA,2019,321(3):256-265.
    [15] YAN JH,GUAN BJ,GAO HY,et al. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease:A meta-analysis of randomized controlled trials[J].Medicine(Baltimore),2018,97(37):e12271.
    [16] SANYAL AJ,ABDELMALEK MF,SUZUKI A,et al. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial[J].Gastroenterology,2014,147(2):377-384.
    [17] KRAWCZYK M,MACIEJEWSKA D,RYTERSKA K,et al. Gut permeability might be improved by dietary fiber in individuals with nonalcoholic fatty liver disease(NAFLD)undergoing weight reduction[J]. Nutrients,2018,10(11):e1793.
    [18] PROMRAT K,KLEINERK DE,NIEMEIER HM,et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis[J]. Hepatology,2010,51(1):121-129.
    [19] LEUNG C,RIVERA L,FURNESS JB,et al. The role of the gut microbiota in NAFLD[J]. Nat Rev Gastroenterol Hepatol,2016,13(7):412-425.
    [20] XIA MF,BIAN H,ZHU XP,et al. Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults[J]. Clin Nutr,2018,37(5):1752-1758.
    [21] RIPPE JM,ANGELOPOULOS TJ. Fructose-containing sugars and cardiovascular disease[J]. Adv Nutr,2015,6(4):430-439.
    [22] MA J,FOX CS,JACQUES PF,et al. Sugar-sweetened beverage,diet soda,and fatty liver disease in the Framingham Heart Study cohorts[J]. J Hepatol,2015,63(2):462-469.
    [23] WANG M,ZHANG XJ,FENG K,et al. Dietaryα-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissueliver axis in mice[J]. Sci Rep,2016,6:26826.
    [24] ANGELICO F,LOFFREDO L,PIGNATELLI P,et al. Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome[J]. Intern Emerg Med,2012,7(3):219-227.
    [25] CHAMBERS ES,VIARDOT A,PSICHAS A,et al. Effects of targeted delivery of propionate to the human colon on appetite regulation,body weight maintenance and adiposity in overweight adults[J]. Gut,2015,64(11):1744-1754.
    [26] CHEN Q,FENG Y,YANG H,et al. A vitamin pattern diet is associated with decreased risk of gestational diabetes mellitus in Chinese women:Results from a case control study in Taiyuan,China[J]. J Diabetes Res,2019,2019:5232308.
    [27] KWAK MS,KIM D. Non-alcoholic fatty liver disease and lifestyle modifications,focusing on physical activity[J]. Korean J Intern Med,2018,33(1):64-74.
    [28] ZELBER-SAGI S,BUCH A,YESHUA H,et al. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial[J]. World J Gastroenterol,2014,20(15):4382-4392.
    [29] HASHIDA R,KAWAGUCHI T,BEKKI M,et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease:A systematic review[J]. J Hepatol,2017,66(1):142-152.
    [30] JENSEN MD,RYAN DH,APOVIAN CM,et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society[J]. J Am Coll Cardiol,2014,63(25 Pt B):2985-3023.
    [31] WINN NC,LIU Y,RECTOR RS,et al. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity-A randomized trial[J]. Metabolism,2018,78:128-140.
    [32] KWAK MS,KIM D,CHUNG GE,et al. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance[J]. Liver Int,2015,35(3):944-952.
    [33] KEATING SE,HACKETT DA,PARKER HM,et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity[J]. J Hepatol,2015,63(1):174-182.
    [34] TSUNODA K,KAI Y,KITANO N,et al. Impact of physical activity on nonalcoholic steatohepatitis in people with nonalcoholic simple fatty liver:A prospective cohort study[J]. Prev Med,2016,88:237-240.
    [35] LI Y,HE F,HE Y,et al. Dose-response association between physical activity and non-alcoholic fatty liver disease:A case-control study in a Chinese population[J]. BMJ Open,2019,9(3):e026854.
    [36] ZOU TT,ZHANG C,ZHOU YF,et al. Lifestyle interventions for patients with nonalcoholic fatty liver disease:A network meta-analysis[J]. Eur J Gastroenterol Hepatol,2018,30(7):747-755.
    [37] KENNEALLY S,SIER JH,MOORE JB. Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease:A systematic review[J]. BMJ Open Gastroenterol,2017,4(1):e000139.
    [38] GOLABI P,LOCKLEAR CT,AUSTIN P,et al. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease:Systematic review[J]. World J Gastroenterol,2016,22(27):6318-6327.
    [39] ECKARD C,COLE R,LOCKWOOD J,et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease:A randomized trial[J]. Therap Adv Gastroenterol,2013,6(4):249-259.
    [40] KIM D,KIM WR. Nonobese fatty liver disease[J]. Clin Gastroenterol Hepatol,2017,15(4):474-485.
    [41] WONG VW,CHAN RS,WONG GL,et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease:A randomized controlled trial[J]. J Hepatol,2013,59(3):536-542.
  • 加载中
计量
  • 文章访问数:  835
  • HTML全文浏览量:  12
  • PDF下载量:  209
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-09-16
  • 出版日期:  2020-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回